Retiro De Equipo (Recall) de Philips HeartStart MRx Monitor/Defibrillator

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Philips Electronics Australia Ltd.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
  • ID del evento
  • Clase de Riesgo del Evento
    Class I
  • Fecha de inicio del evento
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    Issue 1: the mrx can be susceptible to interference from electrical fast transients (efts) when connected to ac or dc power, operating with a lan cable, or operating near a source of eft interference, which could cause therapy to be delayed or delivered inadvertently.Issue 2: if a user undertakes certain atypical clinical workflows (ie, when using external paddles for defibrillation or when using the periodic clinical data transmission (pcdt) option on the mrx), the mrx can exhibit unexpected behaviour. these workflows do not correspond to instructions in the mrx instructions for use (ifu) and are not expected to be performed by trained clinicians. in addition, these device behaviours have only been observed during internal testing, and have not been reported during clinical use. issue 3: the mrx could stop demand mode pacing due to an ecg leads-off condition when electrode-to-skin contact impedance values are outside design ranges for detection.
  • Acción
    A software upgrade will be implemented for all units affected by one or more of the above issues. Users are advised that they can continue to use their MRx prior to receiving the software upgrade, provided they follow the temporary workaround instructions provided in the customer letter.



  • Empresa matriz del fabricante (2017)
  • Source